Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis
Ann. hepatol; 16 (2), 2017
ABSTRACT Background and aim. The combination of Sofosbuvir (SOF) and Ledipasvir (LDV) has been lead to considerable enhancement of treatment of hepatitis C virus (HCV) genotype 1 infection. A meta-analysis of the currently available studies was undertaken with the aim to evaluate the antiviral efficacy ...
Antivirales/uso terapéutico, Bencimidazoles/uso terapéutico, Fluorenos/uso terapéutico, Hepacivirus/efectos de los fármacos, Hepatitis C/tratamiento farmacológico, Sofosbuvir/uso terapéutico, Antivirales/efectos adversos, Bencimidazoles/efectos adversos, Distribución de Chi-Cuadrado, Quimioterapia Combinada, Fluorenos/efectos adversos, Genotipo, Hepacivirus/genética, Hepatitis C/diagnóstico, Hepatitis C/virología, Oportunidad Relativa, Ribavirina/uso terapéutico, Sofosbuvir/efectos adversos, Respuesta Virológica Sostenida, Factores de Tiempo, Resultado del Tratamiento